Sulphated hyaluronic acids having a sulphation degree of 3.5 per disaccharide unit, HyalS3.5, were prepared with different molecular weights corresponding to 21 x 10(3), 320 x 10(3) and 3500 x 10(3). The thrombin inhibition in plasma and in the presence of purified molecules, i.e. fibrinogen, antithrombin III (AT III) and heparin cofactor II (HC II), were studied for the three different MW compounds at different concentrations. The thrombin time in plasma depended on the length of the chain, and the two lower MW HyalS3.5 inhibited thrombin both by direct aspecific interaction and via HC II, whereas the activity of the highest MW compound was mainly related to the electrostatic interaction with HC II. The inactivation of FXa serine protease was only attributed to HyalS3.5-AT III complex.

Abatangelo, G., Barbucci, R., Brun, P., Lamponi, S. (1997). Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives. BIOMATERIALS, 18(21), 1411-1415 [10.1016/S0142-9612(97)00089-6].

Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives

Barbucci, Rolando;Lamponi, Stefania
1997-01-01

Abstract

Sulphated hyaluronic acids having a sulphation degree of 3.5 per disaccharide unit, HyalS3.5, were prepared with different molecular weights corresponding to 21 x 10(3), 320 x 10(3) and 3500 x 10(3). The thrombin inhibition in plasma and in the presence of purified molecules, i.e. fibrinogen, antithrombin III (AT III) and heparin cofactor II (HC II), were studied for the three different MW compounds at different concentrations. The thrombin time in plasma depended on the length of the chain, and the two lower MW HyalS3.5 inhibited thrombin both by direct aspecific interaction and via HC II, whereas the activity of the highest MW compound was mainly related to the electrostatic interaction with HC II. The inactivation of FXa serine protease was only attributed to HyalS3.5-AT III complex.
1997
Abatangelo, G., Barbucci, R., Brun, P., Lamponi, S. (1997). Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives. BIOMATERIALS, 18(21), 1411-1415 [10.1016/S0142-9612(97)00089-6].
File in questo prodotto:
File Dimensione Formato  
biomaterials 1997 degradation.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 533.33 kB
Formato Adobe PDF
533.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/41608
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo